Jordan has implemented the Good Governance for Medicines program to address issues of corruption in its pharmaceutical sector. It has completed Phases I and II, which included assessing transparency, developing a national framework, and making some initial improvements. Jordan is now in Phase III of implementation. A steering committee and task force have been established to oversee the program. Phase III activities will focus on training, adopting new procedures, and introducing good governance concepts into university curricula to further promote transparency and accountability.

1. Good Governance for Medicines in Jordan Prof. Mohammad Rawashdeh JFDA Director General

6. PHASE II Development national GGM framework PHASE III Implementation national GGM programme PHASE I National transparency assessment Assessment report GGM framework officially adopted GGM Strategic Plan of Action Good Governance for Medicines programme: a model process Clearance MOH